- Home
- ASTL vs CRMD Comparison
ASTL vs CRMD Comparison
Compare ASTL & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTL
- CRMD
- Stock Information
- Founded
- ASTL 1902
- CRMD 2006
- Country
- ASTL Canada
- CRMD United States
- Employees
- ASTL N/A
- CRMD N/A
- Industry
- ASTL Steel/Iron Ore
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- ASTL Industrials
- CRMD Health Care
- Exchange
- ASTL Nasdaq
- CRMD Nasdaq
- Market Cap
- ASTL 682.6M
- CRMD 645.0M
- IPO Year
- ASTL N/A
- CRMD 2010
- Fundamental
- Price
- ASTL $5.11
- CRMD $6.10
- Analyst Decision
- ASTL
- CRMD Strong Buy
- Analyst Count
- ASTL 0
- CRMD 7
- Target Price
- ASTL N/A
- CRMD $15.14
- AVG Volume (30 Days)
- ASTL 1.4M
- CRMD 2.2M
- Earning Date
- ASTL 03-12-2025
- CRMD 05-08-2025
- Dividend Yield
- ASTL 3.91%
- CRMD N/A
- EPS Growth
- ASTL N/A
- CRMD N/A
- EPS
- ASTL N/A
- CRMD N/A
- Revenue
- ASTL $1,706,096,151.00
- CRMD $43,472,170.00
- Revenue This Year
- ASTL $17.08
- CRMD $192.92
- Revenue Next Year
- ASTL $8.25
- CRMD $56.23
- P/E Ratio
- ASTL N/A
- CRMD N/A
- Revenue Growth
- ASTL N/A
- CRMD N/A
- 52 Week Low
- ASTL $5.06
- CRMD $3.61
- 52 Week High
- ASTL $12.14
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- ASTL 29.04
- CRMD 24.77
- Support Level
- ASTL $5.25
- CRMD $5.88
- Resistance Level
- ASTL $5.66
- CRMD $6.35
- Average True Range (ATR)
- ASTL 0.27
- CRMD 0.61
- MACD
- ASTL -0.03
- CRMD -0.40
- Stochastic Oscillator
- ASTL 2.80
- CRMD 4.04
About ASTL Algoma Steel Group Inc.
Algoma Steel Group Inc is a Canadian company engaged in the production of clean and consistent light gauge steel. The company offers a range of hot and cold rolled steel sheet and plate products. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.